Receiving B12 injections may delay a formal diagnosis of deficiency
Space sessions 12 weeks apart for an initial series, transitioning to monthly maintenance once results are established
Nacuitys molecules are differentiated, prescription-quality, GMP-grade moieties, which, combined with innovative delivery technologies, are poised to address diseases and conditions involving oxidative stress including retinitis pigmentosa, cataract and cystinosis as well as rare neurological diseases
This solution will be used solely in a medical setting under proper guidance
Despite widespread adoption, these agents are not approved by the U.S
***Canadian Customers*** If you are purchasing this product to be shipped to Canada, please click HERE One Product